Global Chondroitin Sulfate Market

Chondroitin Sulfate Market Size, Share, Growth Analysis, By Source(Bovine, Swine), By Application(Nutraceuticals, Pharmaceuticals) - Industry Forecast 2024-2031


Report ID: SQMIG15E2266 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 67 | Figures: 75

Chondroitin Sulfate Market Insights

Chondroitin Sulfate Market size was valued at USD 1.21 Billion in 2021 and is poised to grow from USD 1.25 Billion in 2022 to USD 1.65 Billion by 2030, at a CAGR of 3.5 % during the forecast period (2023-2030).

The increased demand for nutraceutical products and the rising prevalence of osteoarthritis are expected to be the main drivers of chondroitin sulfate demand. The need for the source is anticipated to increase since pharmaceutical-grade chondroitin sulfate is mostly used to treat UTIs, cataracts, and osteoarthritis. Additionally, it is used in the form of drugs to lower the amount of sugar in the blood, stop the spread of tumors, and enhance liver function. Additionally, the growing demand for its use for the management of osteoarthritis and a number of other ailments is predicted to support the rise of the overall market.

Chondroitin sulfate is made up of a lengthy chain of sugars, including glucuronic acid & N-acetylgalactosamine. Chondroitin sulfate can be found in varying amounts in the cartilage, joints, and connective tissues of people. Regular chondroitin sulphate consumption leads to improved joint performance. The item can also be used as an eye spray for dry eyes and in veterinary treatment. Demand on the market is significantly influenced by both meat and the industry that produces it. The market has expanded as a result of increased meat consumption and strong demand from the pet industry for meat-based sources. Animal parts employed in a variety of industries, including kidneys, spleen, liver, brains, & the lungs, are of great nutritional value.

Animal glands and organs, for instance, are used medically in a number of nations, such as Japan, China, and India. Tallow, meat meal, fertilizer, and pet food are all made from the intestines of animals. A source of vitamin B12 and a nutritional supplement, liver extract of pigs and cows is also used to treat various types of anemia. Fish waste that is too bone-heavy or includes a lot of oil is converted into industrial products and feed. Collagen and chondroitin sulphate, which are components in several medicinal, nutraceutical, aesthetically pleasing, and food products, are also obtained from cartilage.

The increasing demand for meat as well as meat products has led to a rise in animal deaths. The fact that cartilage collected after slaughter serves as the chemical's source has been quite useful to those who make it. One of the most common musculoskeletal conditions affecting the elderly is osteoarthritis. Affected joints ache and have limited range of motion. Osteoarthritis is treated with chondroitin sulfate to lessen inflammation, halt the condition's development, and improve associated symptoms. It is projected that osteoarthritis will become more popular as it becomes more common in industrialized countries including the U.S. and the U.K., amongst others.

US Chondroitin Sulfate Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Chondroitin Sulfate Market size was valued at USD 1.21 Billion in 2021 and is poised to grow from USD 1.25 Billion in 2022 to USD 1.65 Billion by 2030, at a CAGR of 3.5 % during the forecast period (2023-2030).

The chondroitin sulfate market is fragmented in nature because there are so many manufacturers, particularly in China. There is fierce competition in the sector as a result of the increased R&D expenditures for resource innovation and enhancing source efficiency. High levels of pricing competition among sources and companies' shifting focus towards increasing use of organic extracts are signs of intense competition. The primary areas that are important for manufacturers are the sourcing of sustainable raw materials and efficient sourcing strategies. Companies are using cartilage having a high purity concentration to create the sources. For instance, ZPD offers various grades that include sodium chondroitin sulfate in amounts of 20%, 40%, and 80%, as well as additional varieties of sodium chondroitin sulfate ingredients that are compliant with rules for pet food producers. 'Synutra Ingredients', 'TSI Group Ltd.', 'Bioiberica', 'Seikagaku Corporation', 'Shandong Runxin Biotechnology Co., Ltd.', 'Jiaxing Hengjie Biopharmaceutical Co., Ltd.', 'Summit Nutritionals International Inc.', 'Bio-gen Extracts Pvt. Ltd.', 'Yantai Dongcheng Pharmaceutical Group Co., Ltd.', 'Sioux Pharm, Inc.', 'Pacific Rainbow International, Inc.', 'ZPD A/S', 'Bausch Health Companies Inc.', 'Jiaxing Yueteng Biological Technology Co., Ltd.', 'San Xinyuan Food Industry Co., Ltd.', 'Zeria Pharmaceutical Co., Ltd.', 'YBCC (Yantai BeiYang Chemtech Co., Ltd.)', 'Marcor Development Corporation', 'Huiwen Pharmaceutical (Shandong) Co., Ltd.', 'Qingdao Green-Extract Biology Science and Technology Co., Ltd.'

As the population continues to age, there is a higher incidence of joint-related ailments such as osteoarthritis. Chondroitin sulfate is commonly used in the treatment of osteoarthritis as it helps in reducing pain, inflammation, and improving joint function. The aging population is a significant driver for the chondroitin sulfate market.

Increasing Demand for Natural and Organic Ingredients: There is a growing preference among consumers for natural and organic products, including supplements and nutraceuticals. This trend has led to an increased demand for chondroitin sulfate derived from natural sources such as bovine, porcine, and marine origins. Manufacturers are focusing on offering chondroitin sulfate products that meet these consumer preferences.

North America dominated the market with a 36.2% revenue share in 2022. This is attributable to the FDA's approval of the use of goods including sodium chondroitin sulfate as well as the expansion of the American pharmaceutical sector. Demand is also expected to be fueled by factors including the rising prevalence of osteoarthritis, rising use of cholesterol medication, cataract surgery, or formulations for eye drops. A few companies in Europe use chondroitin sulfate, but those that do include those in the pharmaceutical, cosmetics, food, animal feed, and veterinary fields. In dietary supplements, chondroitin sulfate is a substitute medicine used to treat osteoarthritis.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Chondroitin Sulfate Market

Product ID: SQMIG15E2266

$5,300
BUY NOW GET FREE SAMPLE